ArticleScience advances2025
Commodifying a carcinogen: Critical raw materials from arsenic-laden groundwater.
Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Experimental and geochemical modeling study of coexisting Arsenic(III) and Arsenic(V) removal by ferrihydrite.Scientific reports · 2026Article
- Upcycling Metal(loid) Contaminants to Produce Critical Raw Materials: The Nexus of Water Treatment and Material Criticality.Environmental science & technology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Arsenic is a potent carcinogen whose presence in groundwater poses a persistent global public health threat. While groundwater treatment mitigates arsenic exposure, it generates concentrated arsenic-rich by-products that are universally considered economic and environmental burdens. However, arsenic is experiencing a renaissance. Both the United States and European Union have classified arsenic as a critical raw material (CRM) due to the role of metallic arsenic [As(0)] in materials needed for digital infrastructure and clean energy systems. Bringing these two material flows together, we show that arsenic removed during groundwater treatment can be transformed into pure amorphous As(0) nanoparticles via a two-stage process of alkali extraction and selective reduction. The creation of valuable CRMs from carcinogenic treatment by-products is a potentially disruptive technology for the water sector that can alter global As(0) supply chains. Revenue from upcycled As(0) can also help improve the challenging economics of water treatment in marginalized arsenic-affected regions.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.